Cipla and Hetero to launch cut-price darbepoetin in India
This article was originally published in Scrip
Executive Summary
Cipla has entered into an alliance with the local firm Hetero Drugs to introduce a cut-price biosimilar darbepoetin alfa on the Indian market.